Skip to content
[P]pubcas
Independent chemical reference Compare
Home/Chemicals/99011-02-6
Chemical substance record

Imiquimod

99011-02-6C14H16N4240.31 g/mol
Organic/Inorganic Small MoleculeChEBI source record

An imidazoquinoline fused [4,5-c] carrying isobutyl and amino substituents at N-1 and C-4 respectively. A prescription medication, it acts as an immune response modifier and is used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Search SDS PDFs Sigma-Aldrich Thermo Fisher

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number99011-02-6ChEBI ↗
Molecular formulaC14H16N4ChEBI ↗
Molar mass240.31 g/molChEBI ↗
Monoisotopic mass240.1375 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:36704ChEBI ↗

Cross-source molecular data

PubChem
Molar mass240.30 g/molPubChem ↗
Exact mass240.137496527 DaPubChem ↗
Computed XLogP2.6PubChem ↗
Topological polar surface area (Ų)56.7PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors3PubChem ↗
Rotatable bonds2PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
imiquimod
1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine
DOUYETYNHWVLEO-UHFFFAOYSA-N
CC(C)Cn1cnc2c(N)nc3ccccc3c21
InChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)

Names & synonyms

1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amineimiquimodum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology
imidazoquinolineChEBI parent class · 38776 ↗
organic heterocyclic compoundorganic molecular entity

Roles recorded in ChEBI

antiviral agentantineoplastic agentinterferon inducerantimalarialhepatoprotective agentanti-HBV agentantileishmanial agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00416129 mol

Uses 240.31 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 14 atoms
69.97%
N
Nitrogen · 4 atoms
23.31%
H
Hydrogen · 16 atoms
6.71%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Immunomodulatory and pharmacologic properties of imiquimod. ↗Journal of the American Academy of Dermatology · 2000 Jul · PMID 10861101
Viral and nonviral uses of imiquimod: a review. ↗Journal of cutaneous medicine and surgery · 2004 Sep-Oct · PMID 15868314
AU2005320890 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
EP1831219 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
KR20070102652 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
Search PubMed Google Scholar

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:36704

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 57469 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.

How this record was assembledSuggest a correction